ATLASBioRestorative Therapies (BRTX) earnings date: Nov 11, 2026
BioRestorative Therapies (BRTX) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026. Analysts expect EPS of -$2.60.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BRTX
| Last price | $1.50 (+7.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.4% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 6 reports |
These figures come from the same calibrated model and valuation as the BioRestorative Therapies stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
BioRestorative Therapies reports on Nov 11, 2026. One email the day before, with ATLAS’s read on BioRestorative Therapies. You can switch it off at any time.
Alert me before BRTX reportsFree to start. Creating an account takes under a minute.
Notify me when BioRestorative Therapies reports
Track BRTX free Add BioRestorative Therapies to a free ATLAS watchlist and see its next report date in one place.
BRTX earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$2.60 |
| Last report | Sep 29, 2026 · Beat |
| Beat rate (last 6 reports) | 5 of 6 (83%) |
| Average EPS surprise | +23.4% |
| Average move around a report | ±8.6% (last 6) |
| Sector | Healthcare · Biotechnology |
BioRestorative Therapies earnings history: last 6 reports
BioRestorative Therapies last reported on Sep 29, 2026: EPS of $6.00 against an estimate of $3.00 (+100.0% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Sep 29, 2026 | $3.00 | $6.00 | +100.0% | Beat | +0.9% |
| May 14, 2026 | -$6.00 | -$2.40 | +60.0% | Beat | +3.3% |
| Apr 28, 2026 | $4.82 | $4.97 | +3.1% | Beat | -13.3% |
| Mar 26, 2026 | -$7.40 | -$6.40 | +13.5% | Beat | -4.1% |
| Mar 13, 2026 | $1.51 | $1.59 | +5.3% | Beat | -6.5% |
| Feb 23, 2026 | $1.01 | $0.59 | -41.6% | Miss | +23.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BRTX
See the fair value, the probability range and the earnings history of BioRestorative Therapies on its ATLAS page.
BioRestorative Therapies (BRTX) stock analysisPlans from €3.99 a month.
BioRestorative Therapies earnings: frequently asked questions
When does BioRestorative Therapies (BRTX) report earnings?
BioRestorative Therapies is scheduled to report on Wednesday, November 11, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for BRTX?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$2.60 per share (USD). Estimates can change before the report.
How often does BRTX beat earnings estimates?
Of its last 6 reports with a recorded result, BioRestorative Therapies beat the EPS estimate 5 times; the average surprise was +23.4%. Past results do not predict the next one.
How much does BRTX move around earnings?
Over its last 6 reports the stock moved an average of 8.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 6 times.
Did BioRestorative Therapies beat earnings estimates last quarter?
BioRestorative Therapies last reported on Sep 29, 2026: EPS of $6.00 against an estimate of $3.00 (+100.0% surprise), a beat.
How much does BRTX usually move in a day?
On a normal trading day the ATLAS model puts BRTX’s one-day range at about ±10.4%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer